Reuters logo
BG Medicine sees IPO of 4.5 mln shares at $14-$16/shr
November 13, 2007 / 11:38 AM / 10 years ago

BG Medicine sees IPO of 4.5 mln shares at $14-$16/shr

Nov 13 (Reuters) - BG Medicine Inc registerd its initial public offering of 4.5 million shares at an estimated price of $14 to $16 per share.

The Waltham, Massachusetts-based molecular diagnostics company said in a filing with the U.S. Securities and Exchange Commission that Cowen & Co and Leerink Swann were underwriting the IPO.

The company said it applied for a Nasdaq listing under the symbol “BGMD.” (Reporting by Neetha Mahadevan in Bangalore; Editing by Himani Sarkar)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below